VIPHARMA

VIPHARMA

Saint-Ghislain ·KBO/BCE: BE 0774.494.916

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	31-03-2026	122 d early	2026-00070378
31-12-2024	31-07-2025	17-06-2025	44 d early	2025-00149805
31-12-2023	31-07-2024	12-06-2024	49 d early	2024-00126853
31-12-2022	31-07-2023	05-06-2023	56 d early	2023-00114331

Metric	This company	Sector median	Position in the sector
Solvency	8.9%	13.8%	better than 40% of 242 sector peers
Net result	€10k	€19k	better than 45% of 242 sector peers
Equity	€42k	€94k	better than 36% of 242 sector peers
Gross operating margin	€87k	€319k	better than 19% of 214 sector peers
Staff costs	€33k	€279k	higher than 8% of 214 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€467k
Fixed assets	21/28	€167k
Intangible fixed assets	21	€153k
Tangible fixed assets	22/27	€14k
Current assets	29/58	€301k
Stocks & contracts in progress	3	€173k
Amounts receivable within one year	40/41	€60k
Cash & bank	54/58	€63k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€467k
Equity	10/15	€42k
Contributions / capital	10/11	€100
Accumulated profits (losses)	14	€41k
Amounts payable	17/49	€426k
Amounts payable after one year	17	€110k
Amounts payable within one year	42/48	€316k
Trade debts payable within one year	44	€43k
Income statement
Gross operating margin	9900	€87k
Operating result	9901	€17k
Financial charges	65	€4k
Result before taxes	9903	€13k
Income taxes	67/77	€3k
Net result for the period	9904	€10k
Result to be appropriated	9905	€10k

Summary